Back
JPMorgan Chase & Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
75
JPM
JPMorgan Chase &
Last Price:
$262.81
Seasonality Move:
1.2%
Buy
55
ALNY
Alnylam Pharmaceuticals
Last Price:
$267.17
Seasonality Move:
25.91%
Buy
75
JPMorgan Chase & (JPM)
is a Buy
Is JPMorgan Chase & a Buy, Sell or Hold?
-
The current JPMorgan Chase & [JPM] share price is $260.05. The Score for JPM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
JPM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $266.86. The Score for ALNY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JPM Stock Price Chart
What is JPMorgan Chase &'s stock price today?
-
The JPMorgan Chase & share price today is $260.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPM is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $266.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
JPM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.51 | Buy |
Relative Strength Index (14 RSI): | 66.8 | Buy |
Chaikin Money Flow: | -4277575 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.93 | Buy |
Relative Strength Index (14 RSI): | 55.31 | Buy |
Chaikin Money Flow: | 459021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (233.87 - 264.49) | Buy |
Bollinger Bands (100): | (237.56 - 268.76) | Buy |
JPM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 252.15 | Buy |
20-day SMA: | 243.64 | Buy |
50-day SMA: | 240.72 | Buy |
200-day SMA: | 234.87 | Buy |
8-day EMA: | 252.1 | Buy |
20-day EMA: | 246.33 | Buy |
50-day EMA: | 244.49 | Buy |
200-day EMA: | 233.34 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 265.73 | Buy |
20-day SMA: | 252.89 | Buy |
50-day SMA: | 252.29 | Buy |
200-day SMA: | 259.41 | Buy |
8-day EMA: | 263.42 | Buy |
20-day EMA: | 257.65 | Buy |
50-day EMA: | 254.38 | Buy |
200-day EMA: | 246.22 | Buy |
JPMorgan Chase & Earnings Growth & JPM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.48 per share, an increase this year of $0.01 per share, and an increase next year of $1.02 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
JPMorgan Chase & Technical Analysis
Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |